SMALLCAP World Fund®

American Funds®

Share Class R-2

Prospectus Growth 
 fund Growth

SMALLCAP World Fund may be appropriate for:

  • Investors seeking an opportunity for long-term growth of capital
  • Investors looking to participate in the growth potential of some of the world’s most dynamic companies
  • Investors seeking to add diversification by investing globally


The fund's investment objective is to provide long-term growth of capital.


The fund is managed by Capital Research and Management Company, one of the nation’s oldest, largest and most respected investment management firms. Since 1931, Capital Research has invested with a long-term focus based on thorough research and attention to risk.

Fund information
  • Began operations: 4/30/90
  • Expense ratio:* 1.80%
  • Investment expenses paid annually:† $18.00 for a $1,000 balance
  • Ticker symbol: RSLBX
Top 10 holdings
  1. Bluebird Bio 1.0%
  2. Molina Healthcare 0.8%
  3. AAC Technologies Holdings 0.8%
  4. Kotak Mahindra Bank 0.7%
  5. GW Pharmaceuticals 0.7%
  1. Seria 0.7%
  2. Lions Gate Entertainment 0.7%
  3. Insulet 0.7%
  4. Essent Group 0.7%
  5. Dollarama 0.6%
Where the fund was invested
fund holdings
Past results

Figures shown are past results and are not predictive of results in future periods. Current and future results may be lower or higher than those shown here. For more current information and month-end results, click here. Share price and return will vary, so you may lose money. Investing for short periods makes losses more likely. Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value. 

Average annual total returns through 12/31/17
Class R-2 Shares
  Latest10 years Latest5 years Latest3 years Latestyear
At net asset value 5.44% 11.79% 10.41% 25.88%


Investment results reflect the deduction of applicable fees and expenses and the reinvestment of all distributions. When applicable, investment results reflect fee waivers and/or expense reimbursements, without which results would have been lower. See results without waivers and/or reimbursementsRead details about how waivers and/or reimbursements affect the results for each fund.

Class R shares were first offered on May 15, 2002, and are sold without a sales charge. Class R-2 share returns prior to the date shares first sold are hypothetical. Hypothetical returns prior to the date of first sale were calculated by adjusting Class A share returns without a sales charge for the difference between the Class A share expense ratio and the estimated Class R-2 share expense ratio as of the date of first sale. See the dates of first sale and expense adjustments for Class R-2 shares. Please see the fund prospectus for more information about specific expenses.

In applying any particular asset allocation model to your own individual situation, you should consider your other assets, income and investments. For example, in addition to your retirement plan investments, you should consider any investments (including those in an Individual Retirement Account) and savings accounts.

Investing outside the United States involves risks, such as currency fluctuations, periods of illiquidity and price volatility, as more fully described in the prospectus. These risks may be heightened in connection with investments in developing countries. Investing in smaller companies also involves additional risks, and small-company stocks can fluctuate in price more than larger company stocks.

Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.

Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses, which can be obtained from your plan’s financial professional or downloaded and should be read carefully before investing. You can find a link to the prospectus at the top of the page.